Heterozygote loss of ACE2 is sufficient to increase the susceptibility to heart disease

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of molecular medicine

• Publication date

  2014-04-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00109-014-1149-yPMID 24728465
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiotensin 1–7 Ameliorates Diabetic Cardiomyopathy and Diastolic Dysfunction in db/db Mice by Reducing Lipotoxicity and Inflammation

  2014cited by this paper
• Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS.

  2014cited by this paper
• Loss of p47phox Subunit Enhances Susceptibility to Biomechanical Stress and Heart Failure Because of Dysregulation of Cortactin and Actin Filaments

  2013cited by this paper
• Association of ACE2 genetic variants with blood pressure, left ventricular mass, and cardiac function in Caucasians with type 2 diabetes.

  2012cited by this paper
• Loss of Angiotensin-Converting Enzyme-2 Exacerbates Diabetic Cardiovascular Complications and Leads to Systolic and Vascular Dysfunction: A Critical Role of the Angiotensin II/AT1 Receptor Axis

  2012influential reference
• Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit.

  2011influential reference
• Prevention of Angiotensin II–Mediated Renal Oxidative Stress, Inflammation, and Fibrosis by Angiotensin-Converting Enzyme 2

  2011cited by this paper
• Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction

  2010influential reference
• Loss of PI3K&ggr; Enhances cAMP-Dependent MMP Remodeling of the Myocardial N-Cadherin Adhesion Complexes and Extracellular Matrix in Response to Early Biomechanical Stress

  2010cited by this paper
• Effects of ACE2 inhibition in the post-myocardial infarction heart.

  2010cited by this paper
• Loss of Angiotensin-Converting Enzyme 2 Accelerates Maladaptive Left Ventricular Remodeling in Response to Myocardial Infarction

  2009influential reference
• Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction.

  2009cited by this paper
• Angiotensin(1-7) Blunts Hypertensive Cardiac Remodeling by a Direct Effect on the Heart

  2008cited by this paper
• Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway.

  2008cited by this paper
• Cardiovascular-Renal Mechanisms in Health and Disease Prevention of angiotensin II-induced cardiac remodeling by angiotensin-( 1 – 7 )

  2007cited by this paper
• Role of oxidative stress in cardiac hypertrophy and remodeling.

  2007cited by this paper
• Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice.

  2007cited by this paper
• Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.

  2007cited by this paper
• Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME.

  2006cited by this paper
• Regulation of cardiac hypertrophy by intracellular signalling pathways

  2006cited by this paper
• Deletion of Angiotensin-Converting Enzyme 2 Accelerates Pressure Overload–Induced Cardiac Dysfunction by Increasing Local Angiotensin II

  2006cited by this paper
• Evidence for a Functional Interaction of the Angiotensin-(1–7) Receptor Mas With AT1 and AT2 Receptors in the Mouse Heart

  2005cited by this paper
• Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2

  2005cited by this paper
• G-Protein–Coupled Receptor Mas Is a Physiological Antagonist of the Angiotensin II Type 1 Receptor

  2005cited by this paper
• Myocardial infarction increases ACE2 expression in rat and humans.

  2005cited by this paper
• Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor.

  2005cited by this paper
• &bgr;2- and &bgr;3-adrenoceptor Polymorphisms Accompanied by Heightened Sympathetic Activity Relate to Obesity, Hypertension or Obesity-related Hypertension: P203

  2005cited by this paper
• Opposing Roles of p47phox in Basal Versus Angiotensin II–Stimulated Alterations in Vascular O2− Production, Vascular Tone, and Mitogen-Activated Protein Kinase Activation

  2004cited by this paper
• Upregulation of Angiotensin-Converting Enzyme 2 After Myocardial Infarction by Blockade of Angiotensin II Receptors

  2004cited by this paper
• Contrasting Roles of NADPH Oxidase Isoforms in Pressure-Overload Versus Angiotensin II–Induced Cardiac Hypertrophy

  2003cited by this paper
• Mechanism of Endothelial Cell NADPH Oxidase Activation by Angiotensin II

  2003cited by this paper
• Pivotal Role of a gp91phox-Containing NADPH Oxidase in Angiotensin II-Induced Cardiac Hypertrophy in Mice

  2002cited by this paper
• New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment.

  2002cited by this paper
• Angiotensin-converting enzyme 2 is an essential regulator of heart function

  2002cited by this paper
• Cardiac Angiotensin II Formation in the Clinical Course of Heart Failure and Its Relationship With Left Ventricular Function

  2001cited by this paper
• A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9

  2000cited by this paper
• A Human Homolog of Angiotensin-converting Enzyme

  2000cited by this paper
• Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases.

  2000cited by this paper
• Pathological Hypertrophy and Cardiac Interstitium: Fibrosis and Renin‐Angiotensin‐Aldosterone System

  1991cited by this paper
• Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality

  1991cited by this paper
• Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.

  1990cited by this paper

• Insight into novel therapeutic targets in heart failure: a comprehensive review

  2025cites this paper
• Gene expression profiles, potential targets and treatments of cardiac remodeling

  2024cites this paper
• Role of the RAAS in mediating the pathophysiology of COVID-19

  2024cites this paper
• Wall Shear Stress Reduction Activates Angiotensin II to Facilitate Aneurysmal Subarachnoid Hemorrhage in Intracranial Aneurysms Through miR-29/TGFBR2/Smad3 Axis.

  2023cites this paper
• P21-activated kinase 1 (PAK1)-mediated cytoskeleton rearrangement promotes SARS-CoV-2 entry and ACE2 autophagic degradation

  2023cites this paper
• COVID-19 complications in males and females: recent developments

  2022cites this paper
• Systematic Review on Pathophysiological Complications in Severe COVID-19 among the Non-Vaccinated and Vaccinated Population

  2022cites this paper
• Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies

  2021cites this paper
• Pathophysiological and Clinical Evidence of the Effectiveness of Antioxidant Compounds as a Single or Adjunct Therapy for Hypertension

  2021cites this paper
• Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation

  2021cites this paper
• The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.

  2021cites this paper
• Amplifying Effect of Chronic Lisinopril therapy on Diastolic Function and the Angiotensin-(1-7) Axis by the G1 Agonist in Ovariectomized Spontaneously Hypertensive Rats.

  2021cites this paper
• Dual role for angiotensin‐converting enzyme 2 in Severe Acute Respiratory Syndrome Coronavirus 2 infection and cardiac fat

  2021cites this paper
• Dual targeting of toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment

  2021cites this paper
• ACE2 and energy metabolism: the connection between COVID-19 and chronic metabolic disorders.

  2021cites this paper
• Association of ACE2 receptor and ACEIs/ARBs with disease severity in COVID-19.

  2020cites this paper
• Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System

  2020cites this paper
• The pivotal link between ACE2 deficiency and SARS-CoV-2 infection

  2020cites this paper
• Elevated Angiotensin 1–7/Angiotensin II Ratio Predicts Favorable Outcomes in Patients With Heart Failure

  2020cites this paper
• Could DIZE be the answer to COVID-19?

  2020cites this paper
• SARS-CoV-2 S Protein Binding hACE2: Viral Entry, Pathogenesis, Prognosis, and Potential Therapeutic Targets

  2020cites this paper
• Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones

  2020cites this paper
• Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019

  2020cites this paper
• Hypertensive urgencies and emergencies: Misconceptions and pitfalls.

  2019cites this paper
• The renin-angiotensin system: going beyond the classical paradigms

  2019cites this paper
• Angiotensin‐converting enzyme 2–Angiotensin 1‐7/1‐9 system: novel promising targets for heart failure treatment

  2018cites this paper
• Roles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure.

  2017cites this paper
• Insufficient hypothalamic angiotensin-converting enzyme 2 is associated with hypertension in SHR rats

  2017cites this paper
• The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7)

  2017cites this paper
• Chymase-dependent production of angiotensin II: an old enzyme in old hearts.

  2017cites this paper
• Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure.

  2016cites this paper
• Blood Pressure, Proteases and Inhibitors

  2016cites this paper
• THE ROLE OF THE ACE2/ANG-(1-7)/MASR AXIS IN THE DEVELOPMENT OF OBESITY- HYPERTENSION IN MALE AND FEMALE MICE

  2016cites this paper
• ACE2/Ang 1-7 axis: A critical regulator of epicardial adipose tissue inflammation and cardiac dysfunction in obesity

  2016cites this paper
• Angiotensin-Converting Enzyme 2 Metabolizes and Partially Inactivates Pyr-Apelin-13 and Apelin-17: Physiological Effects in the Cardiovascular System

  2016cites this paper
• Animal Models with a Genetic Alteration of the ACE2/Ang-(1-7)/Mas Axis

  2015cites this paper
• Antagonism of angiotensin 1–7 prevents the therapeutic effects of recombinant human ACE2

  2015cites this paper
• ACE in the hole

  2014influential citation